Today news
About the same in other media
UBS picks 2 pharma stocks that are likely to give 23-26% returns
Reading now: 164
UBS prefers Sun Pharma and Cipla among Indian drugmakers and expects the stocks to return 26% and 23%, respectively, over Friday’s closing.
Ascribing sell ratings to Lupin, Dr Reddy’s Laboratories, Zydus Lifesciences and Aurobindo Pharma, the brokerage said the US generic market has been declining and the pace could worsen.
“In India also, the growth of India pharma market has been slowing and recent trends of sharp increase in unbranded generics is a concern,” said UBS analysts in a client note. “These two markets account for 70-80% of sector profits and would imply lower growth.”
(You can now subscribe to our ETMarkets WhatsApp channel)
Read more on economictimes.indiatimes.com
About this in other media
How major US stock indexes fared Friday, 10/11/2024 abcnews.go.com /2 weeks ago
How major US stock indexes fared Tuesday, 10/8/2024 abcnews.go.com /3 weeks ago
Vivek Kaul: Real estate, data, stories, and stories that sound like data livemint.com /3 weeks ago
Show more
The website fvbb.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
